Abstract
A newly synthesized series of chalcone derivatives containing pyrazole rings were synthesized and evaluated for their cytotoxic activities in vitro against several human cancer cell lines. Most of the prepared compounds showed potential cytotoxicity against human breast cancer cell lines MCF-7, HEPG-2, and HCT-116. Also the compounds were evaluated as antimicrobial agents. The three compounds 3, 4, and 5 were proved to be better anticancer agents than the positive standard doxorubicin with IC50 values (4.7, 4.4, and 3.9 μg/ml) against the same human cancer cell lines, whereas compounds 5 and 6 showed the most active antimicrobial compounds in comparison to the other chalcones.
Similar content being viewed by others
References
Evans, B. E., Rittle, K. E., Bock, M. G., Dipardo, R. M., Freidinger, R. M., Whitter, W. L., et al. (1988). Journal of Medicinal Chemistry, 31, 2235.
Zhengfeng, X., Xuexia, M., Gang, L., & Fangming, L. (2008). Journal of Heterocyclic Chemistry, 45, 1485.
Levai, A. (2004). Journal of Heterocyclic Chemistry, 41, 299.
Levai, A. (2002). Journal of Heterocyclic Chemistry, 39, 1.
Kozlov, N. G., & Gusak, K. N. (2007). Russian Journal of Organic Chemistry, 43, 241.
Mokle, S. S., Sayeed, M. A., Kothawar, & Chopde. (2004). International Journal of Chemical Sciences, 2(1), 96.
Hsieh, H. K., Tsao, L. T., & Wang, J. P. (2000). Journal of Pharmacy and Pharmacology, 52, 163.
Viana, G. S., Bandeira, M. A., & Matos, F. (2003). Journal of Phytomedicine, 10, 189.
Zhao, L. M., Jin, H. S., Sun, L. P., Piao, H. R., & Quan, Z. S. (2005). Bioorganic & Medicinal Chemistry Letters, 15, 5027.
Mukarami, S., Muramatsu, M., Aihara, H., & Otomo, S. (1991). Biochemical Pharmacology, 42, 1447.
Liu, M., Wilairat, P., & Go, L. M. (2001). Journal of Medicinal Chemistry, 44, 4443.
Francesco, E., Salvatore, G., Luigi, M., & Massimo, C. (2007). Phytochemistry, 68, 939.
Onyilagna, J. C., Malhotra, B., Elder, M., & Towers, G. H. N. (1997). Canadian Journal of Plant Pathology, 19, 133.
Nielsen, S. F., Chen, M., Theander, T. G., Kharazmi, A., & Christensen, S. B. (1995). Bioorganic & Medicinal Chemistry Letters, 5, 449.
Miranda, C. L., Aponso, G. L. M., Stevens, J. F., Deinzer, M. L., & Buhler, D. R. (2000). Journal of Agricultural and Food Chemistry, 48, 3876.
Siva Kumar, P. M., Geetha Babu, S. K., & Mukesh, D. (2007). Chemical and Pharmaceutical Bulletin, 55, 44.
Satyanarayana, M., Priti, T., Tripathi, K., Srivastava, A. K., & Ram, P. (2004). Bioorganic & Medicinal Chemistry, 12, 883.
Barford, L., Kemp, K., Hansen, M., & Kharazmi, A. (2002). International Immunopharmacology, 2, 545.
Ko, H. H., Tsao, L. T., Yu, K. L., Liu, C. T., Wang, J. P., & Lin, C. N. (2003). Bioorganic & Medicinal Chemistry, 11(Yu KL), 105.
Deshpande, A. M., Argade, N. P., Natu, A. A., & Eckman. (1999). Bioorganic & Medicinal Chemistry, 7, 1237.
Khatib, S., Nerya, O., Musa, R., Shmnel, M., Tamir, S., & Vaya, J. (2005). Bioorganic & Medicinal Chemistry, 13, 433.
Severi, F., Benvenuti, S., Costantino, L., Vampa, G., Melegari, M., & Antolini, L. (1998). European Journal of Medicinal Chemistry, 33, 859.
Talley, J.J., Shikorski, A., James, G., Matthew, C., Jaffreys; PCT. Int. Appl. WO 96 38, 418 (Cl.C07D231/12); [C.A. 126 (1997) 104081p]
Manfred, M. L.; Hans-Joachim, V. Klaus; Ger. Offen. DE 19 521, 822 (Cl. C07D 231/38); [C. A. 126 (1997) 117969j]
Paolo, L. M.; Stefano, S.; Daniele, P.; Alssandra; PCT. Int. Appl. WO 96 40, 704 (Cl. C07419/04), 19 Dec. 1996; [C. A. 126 (1997) 118161b].
Yamamoto, S., Aizu, E., Jiang, H., Nakadate, T., Kiyoto, I., Wang, J. C., et al. (1991). Carcinogenesis, 12, 317–323.
Satomi, Y. (1993). International Journal of Cancer, 55, 506–514.
Shibata, S. (1994). Stem Cells, 12, 44–52.
De Vincenzo, R., Scambia, G., & Mancuso, S. (1995). Anti-Cancer Drug Design, 10, 481–490.
Makita, H., Tanaka, T., Fujitsuka, H., Tatematsu, N., Satoh, K., Hara, A., et al. (1996). Cancer Research, 56, 4904–4909.
Buommino, E., Nicoletti, R., Gaeta, G. M., Orlando, C. M., Baroni, A., & Tufano, M. A. (2004). Cell Proliferation, 37, 413.
Hijova, E. (2006). Bratislavské Lekgrske Listy, 107, 80–84.
Lawrence, N. J., Patterson, R. P., Ooi, L.-L., Cook, D., & Ducki, S. (2006). Bioorganic & Medicinal Chemistry Letters, 16, 5844–5848.
Yang, E. B., Guo, Y. J., Zang, K., Chen, Y. Z., & Mack, P. (2001). Biochimica et Biophysica Acta, 1150, 144–152.
Sabzevari, O., Galati, G., Moridani, M. Y., Siraki, A., & O’Brien, P. J. (2004). Chemico-Biological Interactions, 148, 57–67.
Land, G. A. (1992). Culture media. In H. D. Isenberg (Ed.), Clinical microbiology procedures handbook (Vol. 1). Washington, DC: American Society for Microbiology.
Thom and Church, 1926, the Aspergilli, 39.
Emmons, C. W., Binford, C. H., Utz, J. P., & Kwon-Chung, K. J. (1977). Medical mycology (3rd ed., p. 535). Philadelphia: Lea & Febiger.
Skehan, P., Storeng, R., et al. (1990). Journal of the National Cancer Institute, 82, 1107–1112.
Bauer, A. W., Kirby, W. M., Sherris, C., & Turck, M. (1966). American Journal of Clinical Pathology, 45, 493–496.
Pfaller, M. A., Burmeister, L., Bartlett, M. A., & Rinaldi, M. G. (1988). Journal of Clinical Microbiology, 26, 1437–1441.
National Committee for Clinical Laboratory Standards. (2003). Method for antifungal disk diffusion susceptibility testing of yeast: proposed guideline M44-P. Wayne: NCCLS.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mohamed, M.F., Mohamed, M.S., Shouman, S.A. et al. Synthesis and Biological Evaluation of a Novel Series of Chalcones Incorporated Pyrazole Moiety as Anticancer and Antimicrobial Agents. Appl Biochem Biotechnol 168, 1153–1162 (2012). https://doi.org/10.1007/s12010-012-9848-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-012-9848-8